Kohjin Bio Co., Ltd. (TYO:177A)
1,016.00
+15.00 (1.50%)
Jun 3, 2026, 3:30 PM JST
Kohjin Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2,486 | 3,149 | 1,726 | 1,462 | 1,734 |
Cash & Short-Term Investments | 2,486 | 3,149 | 1,726 | 1,462 | 1,734 |
Cash Growth | -21.05% | 82.45% | 18.06% | -15.69% | 47.48% |
Accounts Receivable | 670 | 985 | 917 | 837 | 1,134 |
Other Receivables | 15 | 13 | 9 | 8 | 17 |
Receivables | 685 | 998 | 926 | 845 | 1,151 |
Inventory | 871 | 880 | 683 | 1,101 | 519 |
Other Current Assets | 226 | 39 | 74 | 70 | 29 |
Total Current Assets | 4,268 | 5,066 | 3,409 | 3,478 | 3,433 |
Property, Plant & Equipment | 3,798 | 3,253 | 2,586 | 2,171 | 1,709 |
Long-Term Investments | 742 | 656 | 553 | 468 | 443 |
Other Intangible Assets | 18 | 27 | 2 | 4 | 5 |
Long-Term Deferred Tax Assets | 77 | 62 | 36 | 11 | 2 |
Other Long-Term Assets | 1 | 2 | 3 | 2 | 3 |
Total Assets | 8,904 | 9,066 | 6,589 | 6,134 | 5,595 |
Accounts Payable | 183 | 209 | 246 | 236 | 396 |
Accrued Expenses | 70 | 79 | 63 | 76 | 60 |
Short-Term Debt | 1,500 | 1,500 | 1,500 | 1,200 | 900 |
Current Portion of Long-Term Debt | 150 | 150 | 150 | 864 | 209 |
Current Portion of Leases | 53 | 51 | 52 | 20 | 20 |
Current Income Taxes Payable | 21 | 114 | 56 | 261 | 244 |
Other Current Liabilities | 392 | 384 | 331 | 364 | 369 |
Total Current Liabilities | 2,369 | 2,487 | 2,398 | 3,021 | 2,198 |
Long-Term Debt | 225 | 375 | 525 | - | 1,064 |
Long-Term Leases | 262 | 310 | 242 | 14 | 34 |
Pension & Post-Retirement Benefits | 46 | 46 | 42 | 42 | 34 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 9 |
Other Long-Term Liabilities | 58 | 67 | 40 | 40 | 40 |
Total Liabilities | 2,960 | 3,285 | 3,247 | 3,117 | 3,379 |
Common Stock | 1,253 | 1,253 | 426 | 426 | 426 |
Additional Paid-In Capital | 1,153 | 1,153 | 325 | 325 | 325 |
Retained Earnings | 3,393 | 3,265 | 2,528 | 2,222 | 1,434 |
Comprehensive Income & Other | 145 | 110 | 63 | 44 | 31 |
Shareholders' Equity | 5,944 | 5,781 | 3,342 | 3,017 | 2,216 |
Total Liabilities & Equity | 8,904 | 9,066 | 6,589 | 6,134 | 5,595 |
Total Debt | 2,190 | 2,386 | 2,469 | 2,098 | 2,227 |
Net Cash (Debt) | 296 | 763 | -743 | -636 | -493 |
Net Cash Growth | -61.21% | - | - | - | - |
Net Cash Per Share | 57.91 | 151.27 | -178.39 | -152.70 | -145.55 |
Filing Date Shares Outstanding | 5.11 | 5.11 | 5.11 | 4.17 | 3.39 |
Total Common Shares Outstanding | 5.11 | 5.11 | 4.17 | 4.17 | 3.39 |
Working Capital | 1,899 | 2,579 | 1,011 | 457 | 1,235 |
Book Value Per Share | 1162.85 | 1130.96 | 802.40 | 724.37 | 654.24 |
Tangible Book Value | 5,926 | 5,754 | 3,340 | 3,013 | 2,211 |
Tangible Book Value Per Share | 1159.32 | 1125.67 | 801.92 | 723.41 | 652.77 |
Order Backlog | - | 72.39 | 31.05 | 20.61 | - |